Clinical Trial

IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors

Name: IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors — clinical trial record (NCT07441174)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is a multicenter, open-label, Phase Ib/II clinical study. The study includes Phase Ib-Dose Exploration Stage and Phase II - Efficacy Exploration and Determination Stage.

Trial Details

NCT Number	NCT07441174
Lead Sponsor	InxMed (Shanghai) Co., Ltd. Collaborators: Ranok Therapuetics Co. Ltd., InxMed (Shenzhen) Co.,Ltd.
Conditions	Solid Tumor Cancer, PDAC
Enrollment	92 participants
Start Date	2026-02-28
Primary Completion	2031-02-28 (estimated)
Study Completion	2031-02-28 (estimated)
Updated on ClinicalTrials.gov	2026-02-27